2-amino-5-(4-cyclopropylimidazol-1-yl)-N-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-4-methylbenzamide;6-aminopyridine-2-carbohydrazide;tert-butyl 2-(4,4-difluorocyclohexyl)acetate;carbanide;5-(4-cyclopropylimidazol-1-yl)-N-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-2-fluoro-4-methylbenzamide;5-(4-cyclopropylimidazol-1-yl)-N-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-2-[(4-methoxyphenyl)methylamino]-4-methylbenzamide;6-(4-cyclopropylimidazol-1-yl)-3-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-7-methylquinazolin-4-one;5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methylbenzoic acid;4,4-difluorocyclohexan-1-amine;6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]pyridin-2-amine;tungsten

C169H186F16N43O10W- — CID 159475057

IUPAC2-amino-5-(4-cyclopropylimidazol-1-yl)-N-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-4-methylbenzamide;6-aminopyridine-2-carbohydrazide;tert-butyl 2-(4,4-difluorocyclohexyl)acetate;carbanide;5-(4-cyclopropylimidazol-1-yl)-N-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-2-fluoro-4-methylbenzamide;5-(4-cyclopropylimidazol-1-yl)-N-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-2-[(4-methoxyphenyl)methylamino]-4-methylbenzamide;6-(4-cyclopropylimidazol-1-yl)-3-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-7-methylquinazolin-4-one;5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methylbenzoic acid;4,4-difluorocyclohexan-1-amine;6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]pyridin-2-amine;tungsten
SMILESCC(C)(C)OC(=O)CC1CCC(F)(F)CC1.COc1ccc(CNc2cc(C)c(-n3cnc(C4CC4)c3)cc2C(=O)Nc2cccc(-c3nncn3C3CCC(F)(F)CC3)n2)cc1.Cc1cc(F)c(C(=O)Nc2cccc(-c3nncn3C3CCC(F)(F)CC3)n2)cc1-n1cnc(C2CC2)c1.Cc1cc(F)c(C(=O)O)cc1-n1cnc(C2CC2)c1.Cc1cc(N)c(C(=O)Nc2cccc(-c3nncn3C3CCC(F)(F)CC3)n2)cc1-n1cnc(C2CC2)c1.Cc1cc2ncn(-c3cccc(-c4nncn4C4CCC(F)(F)CC4)n3)c(=O)c2cc1-n1cnc(C2CC2)c1.NC1CCC(F)(F)CC1.NNC(=O)c1cccc(N)n1.Nc1cccc(-c2nncn2C2CCC(F)(F)CC2)n1.[CH3-].[W]
InChIInChI=1S/C35H36F2N8O2.C28H26F2N8O.C27H26F3N7O.C27H28F2N8O.C14H13FN2O2.C13H15F2N5.C12H20F2O2.C6H11F2N.C6H8N4O.CH3.W/c1-22-16-29(38-18-23-6-10-26(47-2)11-7-23)27(17-31(22)44-19-30(39-20-44)24-8-9-24)34(46)42-32-5-3-4-28(41-32)33-43-40-21-45(33)25-12-14-35(36,37)15-13-25;1-17-11-22-20(12-24(17)36-13-23(31-14-36)18-5-6-18)27(39)38(15-32-22)25-4-2-3-21(34-25)26-35-33-16-37(26)19-7-9-28(29,30)10-8-19;1-16-11-20(28)19(12-23(16)36-13-22(31-14-36)17-5-6-17)26(38)34-24-4-2-3-21(33-24)25-35-32-15-37(25)18-7-9-27(29,30)10-8-18;1-16-11-20(30)19(12-23(16)36-13-22(31-14-36)17-5-6-17)26(38)34-24-4-2-3-21(33-24)25-35-32-15-37(25)18-7-9-27(28,29)10-8-18;1-8-4-11(15)10(14(18)19)5-13(8)17-6-12(16-7-17)9-2-3-9;14-13(15)6-4-9(5-7-13)20-8-17-19-12(20)10-2-1-3-11(16)18-10;1-11(2,3)16-10(15)8-9-4-6-12(13,14)7-5-9;7-6(8)3-1-5(9)2-4-6;7-5-3-1-2-4(9-5)6(11)10-8;;/h3-7,10-11,16-17,19-21,24-25,38H,8-9,12-15,18H2,1-2H3,(H,41,42,46);2-4,11-16,18-19H,5-10H2,1H3;2-4,11-15,17-18H,5-10H2,1H3,(H,33,34,38);2-4,11-15,17-18H,5-10,30H2,1H3,(H,33,34,38);4-7,9H,2-3H2,1H3,(H,18,19);1-3,8-9H,4-7H2,(H2,16,18);9H,4-8H2,1-3H3;5H,1-4,9H2;1-3H,8H2,(H2,7,9)(H,10,11);1H3;/q;;;;;;;;;-1;
InChIKeyBTJKAJFEXHYRCZ-UHFFFAOYSA-N
MW3467.45 g/mol
LogP34.00
Rot. Bonds35

About 2-amino-5-(4-cyclopropylimidazol-1-yl)-N-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-4-methylbenzamide;6-aminopyridine-2-carbohydrazide;tert-butyl 2-(4,4-difluorocyclohexyl)acetate;carbanide;5-(4-cyclopropylimidazol-1-yl)-N-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-2-fluoro-4-methylbenzamide;5-(4-cyclopropylimidazol-1-yl)-N-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-2-[(4-methoxyphenyl)methylamino]-4-methylbenzamide;6-(4-cyclopropylimidazol-1-yl)-3-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-7-methylquinazolin-4-one;5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methylbenzoic acid;4,4-difluorocyclohexan-1-amine;6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]pyridin-2-amine;tungsten

2-amino-5-(4-cyclopropylimidazol-1-yl)-N-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-4-methylbenzamide;6-aminopyridine-2-carbohydrazide;tert-butyl 2-(4,4-difluorocyclohexyl)acetate;carbanide;5-(4-cyclopropylimidazol-1-yl)-N-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-2-fluoro-4-methylbenzamide;5-(4-cyclopropylimidazol-1-yl)-N-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-2-[(4-methoxyphenyl)methylamino]-4-methylbenzamide;6-(4-cyclopropylimidazol-1-yl)-3-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-7-methylquinazolin-4-one;5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methylbenzoic acid;4,4-difluorocyclohexan-1-amine;6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]pyridin-2-amine;tungsten (PubChem CID 159475057) has the molecular formula C169H186F16N43O10W- and a molecular weight of 3467.45 g/mol. Its IUPAC name is 2-amino-5-(4-cyclopropylimidazol-1-yl)-N-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-4-methylbenzamide;6-aminopyridine-2-carbohydrazide;tert-butyl 2-(4,4-difluorocyclohexyl)acetate;carbanide;5-(4-cyclopropylimidazol-1-yl)-N-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-2-fluoro-4-methylbenzamide;5-(4-cyclopropylimidazol-1-yl)-N-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-2-[(4-methoxyphenyl)methylamino]-4-methylbenzamide;6-(4-cyclopropylimidazol-1-yl)-3-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-7-methylquinazolin-4-one;5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methylbenzoic acid;4,4-difluorocyclohexan-1-amine;6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]pyridin-2-amine;tungsten.

Molecular Properties

Compound Name2-amino-5-(4-cyclopropylimidazol-1-yl)-N-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-4-methylbenzamide;6-aminopyridine-2-carbohydrazide;tert-butyl 2-(4,4-difluorocyclohexyl)acetate;carbanide;5-(4-cyclopropylimidazol-1-yl)-N-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-2-fluoro-4-methylbenzamide;5-(4-cyclopropylimidazol-1-yl)-N-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-2-[(4-methoxyphenyl)methylamino]-4-methylbenzamide;6-(4-cyclopropylimidazol-1-yl)-3-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-7-methylquinazolin-4-one;5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methylbenzoic acid;4,4-difluorocyclohexan-1-amine;6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]pyridin-2-amine;tungsten
PubChem CID159475057
Molecular FormulaC169H186F16N43O10W-
Molecular Weight3467.45 g/mol
Exact Mass3465.46
IUPAC Name2-amino-5-(4-cyclopropylimidazol-1-yl)-N-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-4-methylbenzamide;6-aminopyridine-2-carbohydrazide;tert-butyl 2-(4,4-difluorocyclohexyl)acetate;carbanide;5-(4-cyclopropylimidazol-1-yl)-N-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-2-fluoro-4-methylbenzamide;5-(4-cyclopropylimidazol-1-yl)-N-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-2-[(4-methoxyphenyl)methylamino]-4-methylbenzamide;6-(4-cyclopropylimidazol-1-yl)-3-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-7-methylquinazolin-4-one;5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methylbenzoic acid;4,4-difluorocyclohexan-1-amine;6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]pyridin-2-amine;tungsten
SMILESCC(C)(C)OC(=O)CC1CCC(F)(F)CC1.COc1ccc(CNc2cc(C)c(-n3cnc(C4CC4)c3)cc2C(=O)Nc2cccc(-c3nncn3C3CCC(F)(F)CC3)n2)cc1.Cc1cc(F)c(C(=O)Nc2cccc(-c3nncn3C3CCC(F)(F)CC3)n2)cc1-n1cnc(C2CC2)c1.Cc1cc(F)c(C(=O)O)cc1-n1cnc(C2CC2)c1.Cc1cc(N)c(C(=O)Nc2cccc(-c3nncn3C3CCC(F)(F)CC3)n2)cc1-n1cnc(C2CC2)c1.Cc1cc2ncn(-c3cccc(-c4nncn4C4CCC(F)(F)CC4)n3)c(=O)c2cc1-n1cnc(C2CC2)c1.NC1CCC(F)(F)CC1.NNC(=O)c1cccc(N)n1.Nc1cccc(-c2nncn2C2CCC(F)(F)CC2)n1.[CH3-].[W]
InChIInChI=1S/C35H36F2N8O2.C28H26F2N8O.C27H26F3N7O.C27H28F2N8O.C14H13FN2O2.C13H15F2N5.C12H20F2O2.C6H11F2N.C6H8N4O.CH3.W/c1-22-16-29(38-18-23-6-10-26(47-2)11-7-23)27(17-31(22)44-19-30(39-20-44)24-8-9-24)34(46)42-32-5-3-4-28(41-32)33-43-40-21-45(33)25-12-14-35(36,37)15-13-25;1-17-11-22-20(12-24(17)36-13-23(31-14-36)18-5-6-18)27(39)38(15-32-22)25-4-2-3-21(34-25)26-35-33-16-37(26)19-7-9-28(29,30)10-8-19;1-16-11-20(28)19(12-23(16)36-13-22(31-14-36)17-5-6-17)26(38)34-24-4-2-3-21(33-24)25-35-32-15-37(25)18-7-9-27(29,30)10-8-18;1-16-11-20(30)19(12-23(16)36-13-22(31-14-36)17-5-6-17)26(38)34-24-4-2-3-21(33-24)25-35-32-15-37(25)18-7-9-27(28,29)10-8-18;1-8-4-11(15)10(14(18)19)5-13(8)17-6-12(16-7-17)9-2-3-9;14-13(15)6-4-9(5-7-13)20-8-17-19-12(20)10-2-1-3-11(16)18-10;1-11(2,3)16-10(15)8-9-4-6-12(13,14)7-5-9;7-6(8)3-1-5(9)2-4-6;7-5-3-1-2-4(9-5)6(11)10-8;;/h3-7,10-11,16-17,19-21,24-25,38H,8-9,12-15,18H2,1-2H3,(H,41,42,46);2-4,11-16,18-19H,5-10H2,1H3;2-4,11-15,17-18H,5-10H2,1H3,(H,33,34,38);2-4,11-15,17-18H,5-10,30H2,1H3,(H,33,34,38);4-7,9H,2-3H2,1H3,(H,18,19);1-3,8-9H,4-7H2,(H2,16,18);9H,4-8H2,1-3H3;5H,1-4,9H2;1-3H,8H2,(H2,7,9)(H,10,11);1H3;/q;;;;;;;;;-1;
InChIKeyBTJKAJFEXHYRCZ-UHFFFAOYSA-N
XLogP34.00
TPSA686.24 Ų
H-Bond Donors11
H-Bond Acceptors48
Rotatable Bonds35
Heavy Atoms239
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5003467.45
LogP ≤ 534.00
H-Bond Donors ≤ 511
H-Bond Acceptors ≤ 1048

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'acyl_hydrazine', 'substructure': 'N/A'}, {'alert_name': 'aniline', 'substructure': 'N/A'}, {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}, {'alert_name': 'hydrazine', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze 2-amino-5-(4-cyclopropylimidazol-1-yl)-N-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-4-methylbenzamide;6-aminopyridine-2-carbohydrazide;tert-butyl 2-(4,4-difluorocyclohexyl)acetate;carbanide;5-(4-cyclopropylimidazol-1-yl)-N-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-2-fluoro-4-methylbenzamide;5-(4-cyclopropylimidazol-1-yl)-N-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-2-[(4-methoxyphenyl)methylamino]-4-methylbenzamide;6-(4-cyclopropylimidazol-1-yl)-3-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-7-methylquinazolin-4-one;5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methylbenzoic acid;4,4-difluorocyclohexan-1-amine;6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]pyridin-2-amine;tungsten with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-amino-5-(4-cyclopropylimidazol-1-yl)-N-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-4-methylbenzamide;6-aminopyridine-2-carbohydrazide;tert-butyl 2-(4,4-difluorocyclohexyl)acetate;carbanide;5-(4-cyclopropylimidazol-1-yl)-N-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-2-fluoro-4-methylbenzamide;5-(4-cyclopropylimidazol-1-yl)-N-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-2-[(4-methoxyphenyl)methylamino]-4-methylbenzamide;6-(4-cyclopropylimidazol-1-yl)-3-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-7-methylquinazolin-4-one;5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methylbenzoic acid;4,4-difluorocyclohexan-1-amine;6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]pyridin-2-amine;tungsten?
The IUPAC name of 2-amino-5-(4-cyclopropylimidazol-1-yl)-N-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-4-methylbenzamide;6-aminopyridine-2-carbohydrazide;tert-butyl 2-(4,4-difluorocyclohexyl)acetate;carbanide;5-(4-cyclopropylimidazol-1-yl)-N-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-2-fluoro-4-methylbenzamide;5-(4-cyclopropylimidazol-1-yl)-N-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-2-[(4-methoxyphenyl)methylamino]-4-methylbenzamide;6-(4-cyclopropylimidazol-1-yl)-3-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-7-methylquinazolin-4-one;5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methylbenzoic acid;4,4-difluorocyclohexan-1-amine;6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]pyridin-2-amine;tungsten (CID 159475057) is 2-amino-5-(4-cyclopropylimidazol-1-yl)-N-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-4-methylbenzamide;6-aminopyridine-2-carbohydrazide;tert-butyl 2-(4,4-difluorocyclohexyl)acetate;carbanide;5-(4-cyclopropylimidazol-1-yl)-N-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-2-fluoro-4-methylbenzamide;5-(4-cyclopropylimidazol-1-yl)-N-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-2-[(4-methoxyphenyl)methylamino]-4-methylbenzamide;6-(4-cyclopropylimidazol-1-yl)-3-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-7-methylquinazolin-4-one;5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methylbenzoic acid;4,4-difluorocyclohexan-1-amine;6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]pyridin-2-amine;tungsten.
What is the SMILES notation for 2-amino-5-(4-cyclopropylimidazol-1-yl)-N-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-4-methylbenzamide;6-aminopyridine-2-carbohydrazide;tert-butyl 2-(4,4-difluorocyclohexyl)acetate;carbanide;5-(4-cyclopropylimidazol-1-yl)-N-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-2-fluoro-4-methylbenzamide;5-(4-cyclopropylimidazol-1-yl)-N-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-2-[(4-methoxyphenyl)methylamino]-4-methylbenzamide;6-(4-cyclopropylimidazol-1-yl)-3-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-7-methylquinazolin-4-one;5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methylbenzoic acid;4,4-difluorocyclohexan-1-amine;6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]pyridin-2-amine;tungsten?
The canonical SMILES for 2-amino-5-(4-cyclopropylimidazol-1-yl)-N-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-4-methylbenzamide;6-aminopyridine-2-carbohydrazide;tert-butyl 2-(4,4-difluorocyclohexyl)acetate;carbanide;5-(4-cyclopropylimidazol-1-yl)-N-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-2-fluoro-4-methylbenzamide;5-(4-cyclopropylimidazol-1-yl)-N-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-2-[(4-methoxyphenyl)methylamino]-4-methylbenzamide;6-(4-cyclopropylimidazol-1-yl)-3-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-7-methylquinazolin-4-one;5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methylbenzoic acid;4,4-difluorocyclohexan-1-amine;6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]pyridin-2-amine;tungsten is CC(C)(C)OC(=O)CC1CCC(F)(F)CC1.COc1ccc(CNc2cc(C)c(-n3cnc(C4CC4)c3)cc2C(=O)Nc2cccc(-c3nncn3C3CCC(F)(F)CC3)n2)cc1.Cc1cc(F)c(C(=O)Nc2cccc(-c3nncn3C3CCC(F)(F)CC3)n2)cc1-n1cnc(C2CC2)c1.Cc1cc(F)c(C(=O)O)cc1-n1cnc(C2CC2)c1.Cc1cc(N)c(C(=O)Nc2cccc(-c3nncn3C3CCC(F)(F)CC3)n2)cc1-n1cnc(C2CC2)c1.Cc1cc2ncn(-c3cccc(-c4nncn4C4CCC(F)(F)CC4)n3)c(=O)c2cc1-n1cnc(C2CC2)c1.NC1CCC(F)(F)CC1.NNC(=O)c1cccc(N)n1.Nc1cccc(-c2nncn2C2CCC(F)(F)CC2)n1.[CH3-].[W].
What is the InChIKey of 2-amino-5-(4-cyclopropylimidazol-1-yl)-N-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-4-methylbenzamide;6-aminopyridine-2-carbohydrazide;tert-butyl 2-(4,4-difluorocyclohexyl)acetate;carbanide;5-(4-cyclopropylimidazol-1-yl)-N-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-2-fluoro-4-methylbenzamide;5-(4-cyclopropylimidazol-1-yl)-N-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-2-[(4-methoxyphenyl)methylamino]-4-methylbenzamide;6-(4-cyclopropylimidazol-1-yl)-3-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-7-methylquinazolin-4-one;5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methylbenzoic acid;4,4-difluorocyclohexan-1-amine;6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]pyridin-2-amine;tungsten?
The InChIKey is BTJKAJFEXHYRCZ-UHFFFAOYSA-N. The full InChI is InChI=1S/C35H36F2N8O2.C28H26F2N8O.C27H26F3N7O.C27H28F2N8O.C14H13FN2O2.C13H15F2N5.C12H20F2O2.C6H11F2N.C6H8N4O.CH3.W/c1-22-16-29(38-18-23-6-10-26(47-2)11-7-23)27(17-31(22)44-19-30(39-20-44)24-8-9-24)34(46)42-32-5-3-4-28(41-32)33-43-40-21-45(33)25-12-14-35(36,37)15-13-25;1-17-11-22-20(12-24(17)36-13-23(31-14-36)18-5-6-18)27(39)38(15-32-22)25-4-2-3-21(34-25)26-35-33-16-37(26)19-7-9-28(29,30)10-8-19;1-16-11-20(28)19(12-23(16)36-13-22(31-14-36)17-5-6-17)26(38)34-24-4-2-3-21(33-24)25-35-32-15-37(25)18-7-9-27(29,30)10-8-18;1-16-11-20(30)19(12-23(16)36-13-22(31-14-36)17-5-6-17)26(38)34-24-4-2-3-21(33-24)25-35-32-15-37(25)18-7-9-27(28,29)10-8-18;1-8-4-11(15)10(14(18)19)5-13(8)17-6-12(16-7-17)9-2-3-9;14-13(15)6-4-9(5-7-13)20-8-17-19-12(20)10-2-1-3-11(16)18-10;1-11(2,3)16-10(15)8-9-4-6-12(13,14)7-5-9;7-6(8)3-1-5(9)2-4-6;7-5-3-1-2-4(9-5)6(11)10-8;;/h3-7,10-11,16-17,19-21,24-25,38H,8-9,12-15,18H2,1-2H3,(H,41,42,46);2-4,11-16,18-19H,5-10H2,1H3;2-4,11-15,17-18H,5-10H2,1H3,(H,33,34,38);2-4,11-15,17-18H,5-10,30H2,1H3,(H,33,34,38);4-7,9H,2-3H2,1H3,(H,18,19);1-3,8-9H,4-7H2,(H2,16,18);9H,4-8H2,1-3H3;5H,1-4,9H2;1-3H,8H2,(H2,7,9)(H,10,11);1H3;/q;;;;;;;;;-1;.
What are the key properties of 2-amino-5-(4-cyclopropylimidazol-1-yl)-N-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-4-methylbenzamide;6-aminopyridine-2-carbohydrazide;tert-butyl 2-(4,4-difluorocyclohexyl)acetate;carbanide;5-(4-cyclopropylimidazol-1-yl)-N-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-2-fluoro-4-methylbenzamide;5-(4-cyclopropylimidazol-1-yl)-N-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-2-[(4-methoxyphenyl)methylamino]-4-methylbenzamide;6-(4-cyclopropylimidazol-1-yl)-3-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-7-methylquinazolin-4-one;5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methylbenzoic acid;4,4-difluorocyclohexan-1-amine;6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]pyridin-2-amine;tungsten?
2-amino-5-(4-cyclopropylimidazol-1-yl)-N-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-4-methylbenzamide;6-aminopyridine-2-carbohydrazide;tert-butyl 2-(4,4-difluorocyclohexyl)acetate;carbanide;5-(4-cyclopropylimidazol-1-yl)-N-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-2-fluoro-4-methylbenzamide;5-(4-cyclopropylimidazol-1-yl)-N-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-2-[(4-methoxyphenyl)methylamino]-4-methylbenzamide;6-(4-cyclopropylimidazol-1-yl)-3-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-7-methylquinazolin-4-one;5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methylbenzoic acid;4,4-difluorocyclohexan-1-amine;6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]pyridin-2-amine;tungsten has a molecular weight of 3467.45 g/mol, XLogP of 34.00, 35 rotatable bonds, 11 hydrogen bond donors, and 48 hydrogen bond acceptors.
Where does this data come from?
All data for 2-amino-5-(4-cyclopropylimidazol-1-yl)-N-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-4-methylbenzamide;6-aminopyridine-2-carbohydrazide;tert-butyl 2-(4,4-difluorocyclohexyl)acetate;carbanide;5-(4-cyclopropylimidazol-1-yl)-N-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-2-fluoro-4-methylbenzamide;5-(4-cyclopropylimidazol-1-yl)-N-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-2-[(4-methoxyphenyl)methylamino]-4-methylbenzamide;6-(4-cyclopropylimidazol-1-yl)-3-[6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]-2-pyridinyl]-7-methylquinazolin-4-one;5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methylbenzoic acid;4,4-difluorocyclohexan-1-amine;6-[4-(4,4-difluorocyclohexyl)-1,2,4-triazol-3-yl]pyridin-2-amine;tungsten is sourced from PubChem (CID 159475057), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).